Back
Speaker illustration

undefined undefined undefined

Presentations

The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy.

Event: Frontiers in CardioVascular Biology 2018

Topic: Stem Cells, Cell Cycle, Cell Senescence, Cell Death

Session: Basic Science - Cardiac Biology and Physiology

Access
Like
Thumbnail

The endocannabinoid system is a novel therapeutic target for muscular dystrophy cardiomyopathy.

Event: ESC Congress 2017

Topic: Stem cells and cell therapy

Session: Best Posters in genomics to therapy

Access
Like
Thumbnail

The role of the endocannabinoid system in modelling muscular dystrophy cardiac disease with induced pluripotent stem cells.

Event: Frontiers in CardioVascular Biology 2016

Topic: Cell growth, differentiation and stem cells - Heart

Session: Cell growth, differentiation and stem cells - Heart

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources